Navigation Links
Abattis Biologix Corporation Begins Trading on Pink Sheets
Date:6/17/2011

VANCOUVER, British Columbia, June 17, 2011 /PRNewswire/ -- Abattis Biologix Corporation (CNSX: FLU) announced today that their shares have commenced trading on the OTC Pink Sheets under the symbol ABBTF. Pink Sheet trading will provide shareholders with liquidity as the company proceeds with financing activities and the preparation of additional disclosure documents for listing on higher tier OTC platforms and other exchanges.

Mike Withrow, CEO of Abattis stated, "This is the first in three steps toward becoming a fully reporting issuer with the SEC. The company is fully reporting in Canada and is in the process of converting to IFRS. It will provide transparency about our company in both countries and better access to its stock in the US, which will attract new investors and expand our stockholder base."

"We continue to strengthen our IP and are preparing to launch our portfolio of proprietary products into strategic distribution channels. Shareholders and investors should expect to see additional news releases in the coming weeks on these and other events and activities as we move toward that goal," added Withrow.

About Abattis Biologix Corp.

Abattis Biologix Corporation is committed to the research, development and marketing of proprietary natural health and wellness solutions that address chronic illnesses through targeted nutritional support.  We manufacture and market the most scientifically advanced natural therapeutic formulas based on proprietary technologies through multiple distribution channels, while providing the highest level of customer service.

Web: www.abattis.com     Twitter:@abattis

Safe Harbor Statement: This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21 E of the Securities Exchange Act of 1934, as amended. Investors are cautioned that these forward-looking statements involve uncertainties and risk that could cause actual performance and results of operations to differ materially from those anticipated.

Media Contact:
Margie Adelman
madelman@adelmanpr.com
916 220 3500

Investor Relations Contact:
Gil Schneider
Gil.schneider@abattis.com
604 828 8600


'/>"/>
SOURCE Abattis Biologix Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Volcano Corporation Presentation at Wells Fargo Conference to be Webcast
2. Theramed Corporation to Launch Glenveigh Products, ebb™ and jetty™ at the Society of Obstetricians and Gynecologists of Canada
3. Mitsubishi Chemical Medience Corporation Receives 510(k) Clearance for PATHFAST® cTnI-II (cardiac Troponin I) Test in U.S.
4. Spectros Corporation Introduces Continuum®, a Broadband Infrared Sensor for Brain and Gut Oximetry
5. AmbiCom Forms Joint Alliance With E-Care Technology Corporation
6. Volcano Corporation Presentation at William Blair Conference to be Webcast
7. President of Minntech Corporation Injured in Plane Crash
8. Translational Sciences Corporation to Launch OncoTrac™ at the American Society of Clinical Oncology (ASCO) Annual Meeting
9. Luminex Corporation to Present at Jefferies 2011 Global Healthcare Conference
10. Volcano Corporation Presentation at Goldman Sachs Conference to be Webcast
11. EMIT Corporation Receives FDA 510(k) Clearance for HypothermX™ Blood and Fluid Warmer.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Research ... MEMS Devices Medical Market Analysis 2016 - Forecast to 2022" ... The report contains up to date financial data ... analysis. Assessment of major trends with potential impact on the ... analysis of market segmentation which comprises of sub markets, regional ...
(Date:6/23/2016)... 23, 2016 Bracket , a leading clinical ... generation clinical outcomes platform, Bracket eCOA (SM) 6.0, at ... 26 – 30, 2016 in Philadelphia , ... Outcome Assessment product of its kind to fully integrate with ... Bracket eCOA 6.0 is a flexible platform for electronic clinical ...
(Date:6/23/2016)... -- Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in ... . ... ... ... Astellas is ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned ... the David Geffen School of Medicine at UCLA. He trained in Internal Medicine at ... fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from PsychTests.com reveals that behind the tendency ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
(Date:6/24/2016)... ... 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida ... their peers for this recognition are considered among the top 2 percent of lawyers ... as members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark ...
(Date:6/24/2016)... ... ... Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair ... hour by 2020 and then adjusting it yearly to increase at the same rate as ... the wage floor does not erode again, and make future increases more predictable. , The ...
Breaking Medicine News(10 mins):